These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 11754355

  • 1. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C, Canella A, Marino M, Tomatis R, Traniello S, Gavioli R.
    Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
    [Abstract] [Full Text] [Related]

  • 2. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z, Zhang H, Rao H, Jiang D, Cong X, Feng B, Wang J, Wei L, Chen H.
    PLoS One; 2012 Jan; 7(6):e38390. PubMed ID: 22701633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F, Eckels DD.
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV.
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [Abstract] [Full Text] [Related]

  • 6. Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C.
    Pingel S, Weyer S, Galle PR, Löhr HF.
    J Med Virol; 2002 Apr; 66(4):472-80. PubMed ID: 11857524
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.
    Cucchiarini M, Kammer AR, Grabscheid B, Diepolder HM, Gerlach TJ, Grüner N, Santantonio T, Reichen J, Pape GR, Cerny A.
    Cell Immunol; 2000 Aug 01; 203(2):111-23. PubMed ID: 11006009
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
    Ibe M, Sakaguchi T, Tanaka K, Saito S, Yokota S, Tanaka T, Shimotohno K, Chujoh Y, Shiratori Y, Omata M, Miwa K, Takiguchi M.
    J Gen Virol; 1998 Jul 01; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, Grakoui A, Rice CM, Kurokohchi K.
    J Virol; 1995 Apr 01; 69(4):2462-70. PubMed ID: 7884894
    [Abstract] [Full Text] [Related]

  • 14. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L, Liu S, Fan GX, Sheng L, Ren HX, Yuan YK.
    Viral Immunol; 2006 Apr 01; 19(4):702-11. PubMed ID: 17201665
    [Abstract] [Full Text] [Related]

  • 15. The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies.
    Löhr HF, Schmitz D, Arenz M, Weyer S, Gerken G, Meyer zum Büschenfelde KH.
    J Hepatol; 1999 Sep 01; 31(3):407-15. PubMed ID: 10488697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, Walker BD, Koziel MJ.
    J Immunol; 1998 Feb 01; 160(3):1479-88. PubMed ID: 9570570
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.
    Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A, Chisari FV.
    J Clin Invest; 1997 Nov 01; 100(9):2376-85. PubMed ID: 9410918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.